484 related articles for article (PubMed ID: 25322151)
21. Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases.
Papotto PH; Reinhardt A; Prinz I; Silva-Santos B
J Autoimmun; 2018 Feb; 87():26-37. PubMed ID: 29203226
[TBL] [Abstract][Full Text] [Related]
22. Th17 cells and Tregs: unlikely allies.
Chen X; Oppenheim JJ
J Leukoc Biol; 2014 May; 95(5):723-731. PubMed ID: 24563509
[TBL] [Abstract][Full Text] [Related]
23. New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases.
Xu L; Song X; Su L; Zheng Y; Li R; Sun J
Int Immunopharmacol; 2019 Jul; 72():322-329. PubMed ID: 31005777
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.
Yan L; Hu F; Yan X; Wei Y; Ma W; Wang Y; Lu S; Wang Z
J Mol Med (Berl); 2016 Sep; 94(9):1063-79. PubMed ID: 27052830
[TBL] [Abstract][Full Text] [Related]
25. IL-2 therapy in type 1 diabetes: "Trials" and tribulations.
Long SA; Buckner JH; Greenbaum CJ
Clin Immunol; 2013 Dec; 149(3):324-31. PubMed ID: 23499139
[TBL] [Abstract][Full Text] [Related]
26. Th17 cells in inflammation and autoimmunity.
Singh RP; Hasan S; Sharma S; Nagra S; Yamaguchi DT; Wong DT; Hahn BH; Hossain A
Autoimmun Rev; 2014 Dec; 13(12):1174-81. PubMed ID: 25151974
[TBL] [Abstract][Full Text] [Related]
27. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases.
Noack M; Miossec P
Autoimmun Rev; 2014 Jun; 13(6):668-77. PubMed ID: 24418308
[TBL] [Abstract][Full Text] [Related]
28. Fine tuning subsets of CD4
Zhao Z; Zhang X; Su L; Xu L; Zheng Y; Sun J
Int Immunopharmacol; 2018 Mar; 56():269-276. PubMed ID: 29414661
[TBL] [Abstract][Full Text] [Related]
29. How GRAIL controls Treg function to maintain self-tolerance.
Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
[TBL] [Abstract][Full Text] [Related]
30. Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases.
Moudgil KD
Cytokine; 2015 Jul; 74(1):1-4. PubMed ID: 26026376
[TBL] [Abstract][Full Text] [Related]
31. Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases.
Tahvildari M; Dana R
J Immunol; 2019 Dec; 203(11):2749-2755. PubMed ID: 31740549
[TBL] [Abstract][Full Text] [Related]
32. T-cell-based immunotherapy of autoimmune diseases.
Ulivieri C; Baldari CT
Expert Rev Vaccines; 2013 Mar; 12(3):297-310. PubMed ID: 23496669
[TBL] [Abstract][Full Text] [Related]
33. IL-2-based approaches to Treg enhancement.
Harris F; Berdugo YA; Tree T
Clin Exp Immunol; 2023 Mar; 211(2):149-163. PubMed ID: 36399073
[TBL] [Abstract][Full Text] [Related]
34. Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review.
Nakken B; Bodolay E; Szodoray P
Clin Rev Allergy Immunol; 2015 Oct; 49(2):152-62. PubMed ID: 25274451
[TBL] [Abstract][Full Text] [Related]
35. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
36. Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.
Rosenzwajg M; Churlaud G; Mallone R; Six A; Dérian N; Chaara W; Lorenzon R; Long SA; Buckner JH; Afonso G; Pham HP; Hartemann A; Yu A; Pugliese A; Malek TR; Klatzmann D
J Autoimmun; 2015 Apr; 58():48-58. PubMed ID: 25634360
[TBL] [Abstract][Full Text] [Related]
37. Altered Th17/Treg balance and dysregulated IL-1β response influence susceptibility/resistance to experimental autoimmune arthritis.
Venkatesha SH; Dudics S; Weingartner E; So EC; Pedra J; Moudgil KD
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):318-28. PubMed ID: 26227656
[TBL] [Abstract][Full Text] [Related]
38. Graded RhoA GTPase Expression in Treg Cells Distinguishes Tumor Immunity From Autoimmunity.
Kalim KW; Yang JQ; Modur V; Nguyen P; Li Y; Zheng Y; Guo F
Front Immunol; 2021; 12():726393. PubMed ID: 34721389
[TBL] [Abstract][Full Text] [Related]
39. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
40. IL-4/IL-13 Heteroreceptor Influences Th17 Cell Conversion and Sensitivity to Regulatory T Cell Suppression To Restrain Experimental Allergic Encephalomyelitis.
Barik S; Ellis JS; Cascio JA; Miller MM; Ukah TK; Cattin-Roy AN; Zaghouani H
J Immunol; 2017 Oct; 199(7):2236-2248. PubMed ID: 28801358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
